Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kevin Farmer

Orthopaedic Surgery Gainesville, FL Medical Doctor

NPI 1396882304 CMS profile 199289

1600 Sw Archer Rd, Gainesville, FL 32610

Open in the dashboard

General payments

$771,670

752 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$155,330 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Kevin Farmer of Gainesville, FL is reported in the CMS Open Payments database as having received $771,670 across 752 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $155,330 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $203,176 96
2024 General $109,900 123
2023 General $129,138 168
2022 General $115,681 140
2021 General $72,098 85
2020 General $33,981 49
2019 General $107,696 91

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Farmer
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kevin Farmer were reported at $203,176. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kevin Farmer Orthopaedic Surgery median Middle half National median
2019 $107,696 $644 $140–$2,844 $163
2020 $33,981 $312 $75–$1,860 $114
2021 $72,098 $520 $117–$2,495 $132
2022 $115,681 $598 $128–$2,731 $149
2023 $129,138 $461 $128–$2,264 $160
2024 $109,900 $497 $134–$2,475 $164
2025 $203,176 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $646,850 604 payments
  2. Exactech, Inc. $83,464 64 payments
  3. Arthrosurface Incorporated $8,119 12 payments
  4. Anika Therapeutics, Inc. $7,606 12 payments
  5. CGG Medical Inc $7,180 20 payments
  6. Baudax Bio Inc. $5,714 5 payments
  7. Collagen Matrix, Inc $4,063 2 payments
  8. Synthes GmbH $2,878 2 payments
  9. Pacira Pharmaceuticals Incorporated $2,388 1 payment
  10. Linvatec Corporation $510 5 payments
  11. Other $2,899 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $536,783 70 payments
  2. Consulting Fee $175,917 74 payments
  3. Travel and Lodging $33,191 114 payments
  4. Food and Beverage $18,875 490 payments
  5. Honoraria $3,705 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  7. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. EQUINOXE Orthopaedic $50,458 34 payments
  2. Equinoxe Orthopaedic $23,242 23 payments
  3. HemiCAP Shoulder $8,092 11 payments
  4. Integrity $7,079 6 payments
  5. ANJESO $5,714 5 payments
  6. EQUINOXE Orthopaedic $4,500 1 payment
  7. Exparel $2,388 1 payment
  8. Zilretta $2,388 1 payment
  9. Iovera $2,388 1 payment
  10. RevoMotion $1,060 5 payments
  11. Other $6,126 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$53,413

Of which drugs: $150

Medicare patients

179

Average age 71

Services billed

1,436

87 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 29%
Depression 28%
Diabetes 23%
Chronic kidney disease 17%
COPD 15%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 23 1,101 $109

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

752 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record